论文部分内容阅读
自王氏1973年报导应用环磷酰胺治疗流行性出血热(下称出血热)后,国内用同样方法治疗本病取得了疗效好、病死率低的成效。但环磷酰胺的剂量以及方法未见有进一步的报导。我院1979年用环磷酰胺治疗出血热28例疗效显著。1980年以来我们进行两种不同剂量的环磷酰胺治疗出血热125例,效果满意,现报道如下: 临床资料本文125例病人入院后随机分配用环磷酰胺200毫克和400mg两组治疗。环磷酰胺200mg组(下称200mg组)59
Since Wang’s application of cyclophosphamide in the treatment of epidemic hemorrhagic fever (hereinafter referred to as hemorrhagic fever) in 1973 has been reported, the domestic use of the same method to treat this disease has achieved good efficacy and low mortality. However, the dose of cyclophosphamide and methods have not been further reported. In our hospital in 1979 with cyclophosphamide in the treatment of hemorrhagic fever in 28 cases of significant effect. Since 1980, we conducted two different doses of cyclophosphamide in the treatment of 125 cases of hemorrhagic fever with satisfactory results, are reported as follows: Clinical data 125 patients admitted to hospital after random allocation of cyclophosphamide 200 mg and 400mg two groups of treatment. Cyclophosphamide 200 mg group (hereinafter 200 mg group) 59